Pfizer Foundation Inc. Grantmaking

Pfizer Foundation Inc. Grantmaking is sponsored by Pfizer Foundation Inc.. Pfizer Foundation Inc. is a corporate foundation based in NEW YORK, NY with assets of approximately $255,288,291.

Pfizer: One of the world's premier biopharmaceutical companies Clinical Trials in Children Integrity and Transparency Plain Language Study Results Expanded Access & Compassionate Use Inflammation & Immunology PfizerPro for Professionals Patient Assistance Programs Behind the Science Features Patient Advocacy & Engagement Diversity, Equity, and Inclusion Environmental Sustainability Stem Cell Research Policy Working with Healthcare Professionals Prescription Value & Pricing Corporate Governance Overview Board Committees & Charters The Pfizer Board Policies Corporate Governance FAQs Research and Business Development Partnerships Submit Your Opportunities Suggestions within Pfizer.

com Pfizer is fighting for 8 cancer breakthroughs by 2030. Every inch. Every day.

Every moment. Matters. Join the fight against cancer and get screened.

In the fight against cancer, every screening, every result, every early detection matters. Join the fight against cancer and get screened at PfizerForAll. com/Screenings.

Pfizer Announces New Discount Program Through TrumpRx Americans who chose to self-pay can now access significant savings on list prices for 30+ Pfizer brands across women’s health, migraine, arthritis, rare diseases, and more.

Season Six of Science Will Win Podcast Takes on Cancer Pfizer's flagship podcast returns to dive into the latest in oncology: the latest challenges, the latest research, the latest treatment approaches, and the latest sources of progress and optimism keeping researchers going.

Behind the Science: A New Path to Tackling Metastatic Breast Cancer In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease. Hiding in Plain Sight: The Racial Toll of Lyme Disease Lyme disease is the most common vector-borne illness in the United States.

New research indicates that people of color are more likely to develop more severe Lyme disease. Behind the Science: Breaking the Cycle of C. difficile The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing!

Clostridioides difficile, also known as C. difficile, is one such bacterium. Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Starting with Charles Pfizer inventing an almond-flavored antiparasite medicine in 1849, our people have always been innovators and trailblazers, committed to finding the next cure.

Pipeline Snapshot as of February 3, 2026 Explore the Product Pipeline Download Complete Pipeline PDF Revolutionary medicines enable us to enrich and extend life for people living with all types of diseases. View All Internal Medicine We’re developing therapies to treat, slow, or prevent disease progression and improve the quality of life for patients with obesity, type 2 diabetes, and cardiovascular and kidney diseases.

Inflammation & Immunology View All Inflammation & Immunology We look for treatments that provide more than just symptom relief, in order to address the root cause of chronic inflammatory diseases at a molecular level Vaccines are the single most important innovation in the science of health to significantly reduce the threat of diseases that were once widespread and oftentimes fatal.

Pipeline & Clinical Trials Cancer treatment needs to be transformed across the entire landscape to significantly improve the lives of cancer patients worldwide. An Accord for a Healthier World Where people live shouldn’t impact the quality of their healthcare and income shouldn’t determine health outcomes.

Learn More About The Accord communications from Pfizer Receive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries.